Cartilage Repair Market

Global Cartilage Repair Market By Modality (Cell Based - Chondrocyte Transplantation, Growth Factor; Non-Cell-Based - Tissue Scaffolds Systems, Cell-Free Composites, Application (Hyaline Cartilage, Fibrocartilage), Treatment Type (Palliative - Viscosupplementation, Debridement & Lavage; Intrinsic Repair Stimulus), Site Outlook (Knee - Arthroscopic Chondroplasty, Autologous Chondrocyte, Osteochondral Grafts, Cell-based Cartilage Resurfacing, Microfracture)

Report Id: KBV-482 Publication Date: June-2018 Number of Pages: 367
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support

Market Report Description

The Global Cartilage Repair Market size is expected to reach $6.4 billion by 2024, rising at a market growth of 8.5% CAGR during the forecast period.

Growing epidemiology of such diseases need effective treatment options, driving the demand for regenerative medicine, which are used in restoring damaged cartilage. The growth of the cartilage repair market can be attributed to changing lifestyle, leading to a number of disorders such as obesity and degenerative joint diseases. The tissue prevents friction between the bones, by absorbing shock in the joints. When damage is caused in the cartilage, it restricts the regular movement of the knee, causing immense pain. It generally occurs after a traumatic and twisting injury to the knee. If cartilage damage remains untreated, it would lead to knee replacement surgery. The aforementioned factors have an influence on cartilage related injuries. These injuries eventually hamper productivity among the working population.

Cartilage Repair Market size

Cartilage Repair Market Size

 

Click Here For Free Insights

The tissue prevents friction between the bones, by absorbing shock in the joints. When damage is caused in the cartilage, it restricts the regular movement of the knee, causing immense pain. It generally occurs after a traumatic and twisting injury to the knee. If cartilage damage remains untreated, it would lead to knee replacement surgery. Knee cartilage repair is generally favourable in conditions such as mal-unions, delayed unions, and slow healing wounds. Advances in knee cartilage repair products have significantly contribute to the growth of this market.

The growth of the cartilage repair market can be attributed to changing lifestyle, leading to a number of disorders such as obesity and degenerative joint diseases. The aforementioned factors have an influence on cartilage related injuries. These injuries eventually hamper productivity among the working population. Growing epidemiology of such diseases need effective treatment options, driving the demand for regenerative medicine, which are used in restoring damaged cartilage.
 

Cartilage Repair Market Share

Cartilage Repair Market Share

Based on Modality, the market is segmented into Cell based and Non-Cell based. Based on Treatment type, the market is segmented into Intrinsic Repair Stimulus and Palliative. Based on Application, the market is segmented into Fibrocartilage and Hyaline Cartilage. Based on Site outlook, the market is segmented into Knee Cartilage and Other site outlook. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include B. Braun Melsungen AG, Zimmer Biomet, Johnson and Johnson, Smith & Nephew Plc., Stryker Corporation, Vericel Corporation, Osiris Therapeutics Inc., Arthrex, Inc., Collagen Solutions Plc., and Anika Therapeutics, Inc.

Scope of the Study

Market Segmentation:

By Modality

  • Cell-Based:
  • Chondrocyte Transplantation    
  • Growth Factor Technology
  • Non-Cell-Based
  • Tissue Scaffolds
  • Cell-Free Composites

By Treatment type

  • Intrinsic Repair Stimulus
  • Palliative
  • Debridement & Lavage
  • Viscosupplementation

By Application

  • Fibrocartilage
  • Hyaline Cartilage

By Site outlook

  • Knee Cartilage Repair
  • Microfracture
  • Arthroscopic Chondroplasty
  • Autologous Chondrocyte
  • Osteochondral Grafts Transplantation
  • Cell-based Cartilage Resurfacing
  • Others
  • Other Site Outlook

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • B. Braun Melsungen AG
  • Zimmer Biomet
  • Johnson and Johnson
  • Smith & Nephew Plc.
  • Stryker Corporation
  • Vericel Corporation
  • Osiris Therapeutics Inc.
  • Arthrex, Inc.
  • Collagen Solutions Plc.
  • Anika Therapeutics, Inc.

Need a report that reflects how COVID-19 has impacted this market and its growth? Download Free Sample Now
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo